U.S. researchers who conducted experiments on mice found that matching transplantable blood stem cells to the mother's cells has a higher chance of achieving success in treating congenital disorders in fetuses. The study, which was published in the Journal of Clinical Investigation, showed that cells that don't match the maternal blood cells are recognized by the mother's immune system as dangerous, leading to transplant rejection.

Full Story:

Related Summaries